Norethindrone

炔诺酮

Report date: 2023/02/08 16:34:08
NME

Base Information

Drug NameNorethindrone
Drug Alias NameNorethisteronePrimolut NJolivetteNorlutinMicronor +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgesterone receptor agonists
TargetsProgesterone receptor
Therapy Area/IndicationsContraceptionMenopausal symptomsMenstruation Disturbances +[5] 
Global Approved IndicationsContraceptionMenopausal symptomsMenstruation Disturbances +[5] 
Approved Indications in ChinaContraceptionMenstruation DisturbancesUterine Hemorrhage +[4] 
Original Approved Country/TerritoryJapan
Original Approved Date1957/10/01
Country/TerritoryUnited StatesEUMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesSearleNovartis Pharma AgTeva Branded Pharmaceutical Products R&D Inc +[4] 
Inactive CompaniesJanssen Pharmaceuticals IncUniversity Of Southern California
Active IndicationsContraceptionMenopausal symptomsMenstruation Disturbances +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeG03AC01G03DC02
Related LinksWikipediaDrugBankKEGG